2021

1. The STARMEN trial indicates that alternating treatment with corticosteroids and cyclophosphamide is superior to sequential treatment with tacrolimus and rituximab in primary membranous nephropathy

   Kidney International, Vol. 99, Núm. 4, pp. 986-998